Sequential Adaptation in Mammalian CHO-K1 Cells Producing Human Erythropoietin

Popi Hadi Wisnuwardhani, Endah Puji Septisetyani, Adi Santoso


The production of recombinant proteins for clinical applications using mammalian cell technology has become a prevalent system because of its capacity in assembling functional proteins.  One of the main problems with CHO-K1 cells is that this cell has to grow in the presence of serum. However, the presence of serum will complicate the downstream step for protein production. Thus, protein produced in media without serum, theoretically, would be easier to purify.  Technically, this type of cell can be produced by growing the CHO-K1 cells in serum-free media by using adaptation method in suspension condition. This research showed that through sequential adaptation using conditioned media, the CHO-K1 cell line that produces the human erythropoietin gene (hEPO) was able to grow in suspension culture using serum-free media.  Based on Western blot analysis, it showed that the protein (hEPO) was able to be expressed in suspension culture with molecular mass of about 47 kDa.


Adaptation, CHO-K1, hEPO, Serum-free media

Full Text:



Anderson DC and Krummen L. 2002. Recombinant protein expression for therapeutic applications. Curr. Opin. Biotechnol. 13: 117–123.

Anderson DC and Reilly DE. 2004. Production technologies for MAbs and their fragments. Curr. Opin.Biotechnol. 15: 456–462.

Allison DW, Aboytes KA, Fong DK, Leugers. TK, Johnson LH and Loke H. 2005. Development and optimization of cell culture media: genomic and proteomic approaches. BioProcess Int. 3: 38–45.

Bragonzi A, Distefano G, Buckberry LD, Acerbis G, Foglieni C, Lamotte D, Campi G, Marc A, Soria MR, Jenkins N, Monaco L. 2000. A new Chinese hamster ovary cell line expressing 2,6-sialyltransferase used as universal host for the production of human-like sialylated recombinant glycoproteins, Biochim. Biophys. Acta 1474: 273–282.

Hannoun Z, Fletcher J, Greenhough S, Medine C, Samuel K, Sharma R, Pryde A. Black JR, Ross JA, Wilmut I, Iredale JP and Hay DC. 2010. The comparison between conditioned media and serum-free media in human embryonic stem cell culture and differentiation. Cell Reprogram. 12: 133-40.

Helenius A and Aebi M. 2001. Intracellular function of N-linked glycans. Science 291: 2364–2369.

Jayapal KP, Wlaschin KF, Hu WS, Yap MGS. 2007. Generation of recombinant Chinese hamster ovary cell lines. Chem. Engin. Progress. 103: 40 – 47.

Jerums, M., and Yang, X. 2005. Optimation of Cell Culture Media. Chapter Four. Bioproses International. P:38-44.

Matasci M, Hacker DL, Baldi L and Wurm FM. 2008. Protein therapeutics recombinant therapeutic protein production in cultivated mammalian cells: current status and future prospects. In: Drug Discovery Today: Technologies, 5: 37-42.

Rader RA. 2006. Biopharmaceutical approval review. Genet. Eng. Biotechnol. News. 26: 14-17.

Reinhart D, Kaisermayer C, Damjanovic L, and Kunert R. 2013. Benchmarking of commercially available CHO cell culture media for antibody production. BMC Proceedings 2013, 7 (S6): P13.

Septisetyani, EP., Rubiyana, R., Wisnuwardhani, PH., Wardiana, A and Santoso, A. 2012. Expression of Recombinant Human Erytrhopoetin with Glycosilation Modification in HEK 293t Cells. Indonesian Journal of Pharmacy , Volume 23(3); 177 – 182. ISSN:0126-1037



  • There are currently no refbacks.

Copyright (c) 2017 ANNALES BOGORIENSES

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Annales Bogorienses Indexed by :





Statistic Visitors